Extracranial Microvascular Complications of Moyamoya Disease Leading to Left Ventricular Systolic Dysfunction

Sohiub N Assaf1, Abdallah N Assaf1, Muaz N Assaf1

  • 1Department of Medicine, The University of Tennessee Graduate School of Medicine, Knoxville, TN 37920, USA.

Insights

Moyamoya disease (MMD), a steno-occlusive condition primarily affecting brain arteries, may also cause cardiac issues. This case suggests extracranial MMD manifestations could impact the heart, warranting further investigation.

Area of Science:

  • Neurology
  • Cardiology
  • Vascular Biology

Background:

  • Moyamoya disease (MMD) is a rare cerebrovascular disorder characterized by progressive stenosis of the internal carotid arteries and the circle of Willis.
  • It primarily affects children and young adults, leading to recurrent ischemic strokes and transient ischemic attacks.
  • The steno-occlusive process in MMD is typically confined to the intracranial circulation.

Observation:

  • This report details a case of MMD presenting with unusual cardiac manifestations.
  • The patient exhibited symptoms suggestive of cardiac dysfunction alongside the known neurological deficits of MMD.
  • The vascular changes observed in MMD are known to occur extracranially.

Findings:

  • The study hypothesizes a potential link between extracranial manifestations of MMD and cardiac involvement.
  • The observed cardiac symptoms in the patient are suspected to be a consequence of the MMD's vascular pathology extending beyond the brain.
  • This suggests that the steno-occlusive process in MMD may affect other organ systems, including the heart.

Implications:

  • This case broadens the understanding of Moyamoya disease, suggesting potential systemic vascular involvement.
  • It highlights the need for comprehensive cardiovascular evaluation in MMD patients.
  • Further research is warranted to elucidate the mechanisms and prevalence of cardiac complications in MMD.

Related Concept Videos

Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
22
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
23
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.4K
Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
25
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
14
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
18